Results

Total Results: 51 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

1. June 2021 CDS Connect Work Group Slides (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdf
   January 01, 2021 - interact, regardless of whether harm ensues Clues About the Frequency of Harm • Clinically important events … 14.3% of inpatients ► 231,000 US emergency department visits • Hospital admissions associated with an adverse … Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. … newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse … drug events.

2. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An Electronic eCQM-Derived CDS (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
   January 01, 2023 - Patient has known adverse reactions to statins. ii. … Patient is likely to have adverse reactions to statins. iii. … are using statins (the numerator) divided by the number of patients at high risk for cardiovascular events … o Modifications to the health IT system such that it will—  Trigger RESTful events to call the CQL … patients who meet one or more of the following criteria (considered at “high risk” for cardiovascular events

3. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdf
   September 01, 2022 - primary and secondary prevention of CVD for patients considered to be at high risk of cardiovascular events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … this component). 9 o Modifications to the health IT system such that it will—  Trigger RESTful events … patients who meet one or more of the following criteria (considered at “high risk” for cardiovascular events

4. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdf
   September 01, 2022 - primary and secondary prevention of CVD for patients considered to be at high risk of cardiovascular events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … this component). 9 o Modifications to the health IT system such that it will—  Trigger RESTful events … patients who meet one or more of the following criteria (considered at “high risk” for cardiovascular events

5. CDS Connect Implementation Guide Draft (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
   October 01, 2017 - USPSTF Grade Definition] Although statin use may be beneficial for the primary prevention of CVD events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

6. CDS Connect Implementation Guide Draft (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
   October 01, 2017 - of the Clinical Statement CMS347v1 measures the number of patients at high risk for cardiovascular events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … DENOMINATOR EXCEPTIONS: Patients with adverse effect, allergy, or intolerance to statin medication.

7. Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure (April 2021) (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
   April 01, 2021 - primary and secondary prevention of CVD for patients considered to be at high risk of cardiovascular events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … Development CMS347v4 measures is a ratio of the number of patients at high risk for cardiovascular events … o Modifications to the health IT system such that it will—  Trigger RESTful events to call the CQL

8. Warfarin-Nsaids Mdia Implementation Guide (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
   November 11, 2019 - With the effectiveness of warfarin in preventing and reducing the occurrence of thromboembolic events … respective health IT products to understand their readiness to implement CQL code and any potential adverse … with the calculated results, and · modifications to the EHR system such that it will · trigger RESTful events … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

9. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
   September 01, 2022 - American Heart Association (AHA) Pooled Cohort Equations (PCE) to calculate the 10- year risk of CVD events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … Testing should also ensure that implementation of the artifact has no adverse effect on the processing …  Trigger RESTful events to call the CQL execution engine.  Interpret the response.

10. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - ;2 however, the ACC/AHA PCE calculates the 10-year risk of atherosclerotic CVD (ASCVD) events.3 CVD … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

11. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
    April 01, 2021 - American Heart Association (AHA) Pooled Cohort Equations (PCE) to calculate the 10-year risk of CVD events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … o Modifications to the health IT system stop:  Trigger RESTful events to call the CQL execution engine … Testing should also ensure that implementation of the artifact has no adverse effect on the processing

12. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2023 - should consider, in consultation with the patient, prescribing a statin for the prevention of CVD events … American Heart Association (AHA) Pooled Cohort Equations (PCE) to calculate the 10- year risk of CVD events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … Testing should also ensure that implementation of the artifact has no adverse effect on the processing

13. CDS Connect Work Group June 2021 Summary (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
    January 01, 2021 - weighs the risk factors to produce a risk array that visually represents the estimated risk of an adverse … The team also runs usability testing with patients and clinicians in separate events.

14. Warfarin-Antidepressants Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … with the calculated results, and · modifications to the EHR system such that it will · trigger RESTful events … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

15. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
    February 01, 2018 - to CDS artifacts, including text and computable versions of the decision logic; suggested trigger events … respective health IT products to understand their readiness to implement CQL code and any potential adverse … the calculated results, and o modifications to the EHR system such that it will  trigger RESTful events … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

16. Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure.pdf (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact_Updated%20Nov%202019.pdf
    November 01, 2019 - primary and secondary prevention of CVD for patients considered to be at high risk of cardiovascular events … Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … for Artifact Development CMS347v3 measures the number of patients at high risk for cardiovascular events … option for this component o Modifications to the health IT system such that it will: Trigger RESTful events

17. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Sept_08.pdf
    February 01, 2018 - to CDS artifacts, including text and computable versions of the decision logic; suggested trigger events … respective health IT products to understand their readiness to implement CQL code and any potential adverse … the calculated results, and o modifications to the EHR system such that it will  trigger RESTful events … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

18. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Modifications to the EHR system such that it will ▪ Trigger RESTful events to call the CQL execution … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

19. Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
    September 01, 2019 - Identified patients should consider using low-to- moderate-dose statins for the prevention of CVD events … American Heart Association (AHA) Pooled Cohort Equations (PCE) to calculate the 10-year risk of CVD events … ;2 however, the ACC/AHA PCE calculates the 10-year risk of atherosclerotic CVD (ASCVD) events.3 CVD … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

20. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
    January 01, 2022 - Identified patients should consider using low- to moderate-dose statins for the prevention of CVD events … American Heart Association (AHA) Pooled Cohort Equations (PCE) to calculate the 10- year risk of CVD events … respective health IT products to understand their capacity to implement CQL code, along with any potential adverse … option for this component). 17 o Modifications to the health IT system to—  Trigger RESTful events … Testing should also ensure that implementation of the artifact has no adverse effect on the processing